These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25028131)

  • 21. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma.
    Li CF; Shen KH; Huang LC; Huang HY; Wang YH; Wu TF
    Pathology; 2010 Jan; 42(1):43-9. PubMed ID: 20025479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annexin A1 is regulated by domains cross-talk through post-translational phosphorylation and SUMOYlation.
    Caron D; Maaroufi H; Michaud S; Tanguay RM; Faure RL
    Cell Signal; 2013 Oct; 25(10):1962-9. PubMed ID: 23727357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
    Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
    Nanda KD; Ranganathan K; Devi U; Joshua E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
    Sobral-Leite M; Wesseling J; Smit VT; Nevanlinna H; van Miltenburg MH; Sanders J; Hofland I; Blows FM; Coulson P; Patrycja G; Schellens JH; Fagerholm R; Heikkilä P; Aittomäki K; Blomqvist C; Provenzano E; Ali HR; Figueroa J; Sherman M; Lissowska J; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Phillips KA; ; Couch FJ; Olson JE; Vachon C; Visscher D; Brenner H; Butterbach K; Arndt V; Holleczek B; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; van de Water B; Broeks A; Chang-Claude J; Chenevix-Trench G; Easton DF; Pharoah PD; García-Closas M; de Graauw M; Schmidt MK
    BMC Med; 2015 Jul; 13():156. PubMed ID: 26137966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Annexin A1 in mouse myoblast cell differentiation.
    Bizzarro V; Fontanella B; Franceschelli S; Pirozzi M; Christian H; Parente L; Petrella A
    J Cell Physiol; 2010 Sep; 224(3):757-65. PubMed ID: 20578244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annexin A1 Expression Capacity as a Determinant for Disease Severity in Crohn's Disease.
    Reischl S; Troger J; Jesinghaus M; Kasajima A; Wilhelm DF; Friess H; Neumann PA
    Dig Dis; 2020; 38(5):398-407. PubMed ID: 32200378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation.
    Rodrigo JP; Garcia-Pedrero JM; Fernandez MP; Morgan RO; Suárez C; Herrero A
    Am J Rhinol; 2005; 19(5):483-7. PubMed ID: 16270603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes.
    Tu Y; Johnstone CN; Stewart AG
    Pharmacol Res; 2017 May; 119():278-288. PubMed ID: 28212890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of the immunohistochemical expression of cytokeratin 8/18 for the diagnosis and classification of breast cancer.
    Cîmpean AM; Suciu C; Ceauşu R; Tătucu D; Mureşan AM; Raica M
    Rom J Morphol Embryol; 2008; 49(4):479-83. PubMed ID: 19050795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annexin A1 localization and its relevance to cancer.
    Boudhraa Z; Bouchon B; Viallard C; D'Incan M; Degoul F
    Clin Sci (Lond); 2016 Feb; 130(4):205-20. PubMed ID: 26769657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression.
    Brotherick I; Robson CN; Browell DA; Shenfine J; White MD; Cunliffe WJ; Shenton BK; Egan M; Webb LA; Lunt LG; Young JR; Higgs MJ
    Cytometry; 1998 Aug; 32(4):301-8. PubMed ID: 9701399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP-2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells.
    Chen Z; Yoshihara E; Son A; Matsuo Y; Masutani H; Sugie K; Maeda M; Yodoi J
    Immunol Lett; 2010 Jun; 131(1):11-8. PubMed ID: 20398702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of lung fibroblast activation by annexin A1.
    Jia Y; Morand EF; Song W; Cheng Q; Stewart A; Yang YH
    J Cell Physiol; 2013 Feb; 228(2):476-84. PubMed ID: 22777765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annexin-A1 regulates TLR-mediated IFN-β production through an interaction with TANK-binding kinase 1.
    Bist P; Shu S; Lee H; Arora S; Nair S; Lim JY; Dayalan J; Gasser S; Biswas SK; Fairhurst AM; Lim LH
    J Immunol; 2013 Oct; 191(8):4375-82. PubMed ID: 24048896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1.
    D'Acunto CW; Fontanella B; Rodriquez M; Taddei M; Parente L; Petrella A
    Cancer Lett; 2010 Sep; 295(1):85-91. PubMed ID: 20227822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.
    Girol AP; Mimura KK; Drewes CC; Bolonheis SM; Solito E; Farsky SH; Gil CD; Oliani SM
    J Immunol; 2013 Jun; 190(11):5689-701. PubMed ID: 23645879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin-A1 - A Blessing or a Curse in Cancer?
    Foo SL; Yap G; Cui J; Lim LHK
    Trends Mol Med; 2019 Apr; 25(4):315-327. PubMed ID: 30871809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
    Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
    Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.